Doxorubicin functions as a mighty warrior against malignant cells. Upon entry, it converts into effective substances that impede the cell's capacity to proliferate and split. It rivals with natural elements necessary for DNA construction, bringing a stop to the DNA strand, shattering it, and inducing the malignant cells to perish. What's unique is that doxorubicin doesn't only battle individually but also enhances its strength by diminishing the generation of certain substances the malignant cells require. This self-enhancing attribute renders doxorubicin a formidable tool against cancer.

• This medication will be given by your physician or nurse; kindly refrain from self administration.
• Avoid consuming it independently; anticipate directions from your physician or nurse.
• Rely on your healthcare expert to distribute the medication; steer clear of attempting self administration.

• Gemcitabine can cause myelosuppression, leading to a decrease in blood cell counts (white blood cells, red blood cells, and platelets). Regular blood tests are necessary to monitor blood cell counts, and the dosage may need adjustment based on these results.
• Gemcitabine may harm the fetus, so it is not recommended during pregnancy Adequate contraception is advised for both men and women during treatment Breastfeeding is not recommended while taking gemcitabine.

• Antimetabolite chemotherapy drug.
• Treats various cancers, including pancreatic cancer .
• Inhibits DNA synthesis in cancer cells .
• Impairs cancer cell proliferation.

• Nausea
• Vomiting
• Breathlessness
• Anemia (low number of red blood cells)
• Blood in urine
• Headache
• Fever
• Diarrhea